Fully laparoscopic bowel closure during anastomosis

Seger's LAP IA 60^TM is the first easy-to-use
closure device that enables
100% laparoscopic anastomosis.

LAP IA 60^TM

SEGER Surgical Solutions was chosen to represent the Society of Surgery of the Alimentary Tract (SSAT) in the 2023 DDW Shark Tank on May 7, 2023.
See you there!

About Us

Seger Surgical Solutions is developing the first easy-to-use closure device that enables 100% laparoscopic anastomosis.

Seger was founded in Israel in 2017. A portfolio company of The Trendlines Group, Seger is located in the Misgav Industrial Park in Israel’s Western Galilee.

Seger’s Novel Solution – LAP IA^TM

Bowel resection surgery involves removing all or part of the intestine. After resection, the surgeon creates a common opening in the two bowel sections to connect them (anastomosis).

Laparoscopic bowel resection and anastomosis is preferred over open surgery because of its clinical benefits to the patient. At present, the majority of these resections and anastomoses are performed outside the abdomen (extracorporeal). The reason for this is the difficulty and complexity of laparoscopic suturing by surgeons.

Seger Surgical Solutions introduces LAP IA 60, a laparoscopic bowel closure device that quickly and securely aligns, closes, and staples the common opening to allow for intracorporeal anastomosis --without the need for suturing.

The device works with a standard 12-millimeter trocar.

With Seger’s LAP IA 60, laparoscopic bowel resection is now 100% laparoscopic!

The LAP IA 60 improves patient care, provides better outcomes, and reduces health care costs.

Improves Patient Care

Fewer surgical site infections (SSIs)
Fewer incisional hernias
Smaller incisions, more cosmetically placed

Results in Better Outcomes

Requires smaller incisions
Eliminates risk of bowel twisting
Reduces need for additional surgery

Cuts Health Care Costs

Reduces procedure time
Reduces post-op complications
Shortens length of stay (LOS)

Our Team

Shahar Millis

CEO

B.Sc., MBA with more than 19 years’ experience in medical device management and R&D, CEO of Fidmi Medical (GI), experience in cardiovascular and gastrointestinal, leading product development from concept to market.

Prof. Barry Salky

Co-Founder & Medical President

Recognized worldwide pioneer and key opinion leader in the laparoscopic surgery field, developed techniques now considered standard of practice; founder, Laparoscopic Surgery Division, Mount Sinai Hospital, NYC; former VP, SAGES; president, International Federation of Surgical Endoscopic Societies (IFSES)

Leo R. Mindick

Co-Founder & Investor

Founder and CEO, Med-Tech Consultant Partners; years of experience in specialty medical devices, IP, regulatory, reimbursement; founder and former CEO, multimillion-dollar specialty medical distribution company (later acquired)